Hemoglobin H Disease; First Case of Hemoglobin H Variant Type (-α3.7/ --SEA) in Costa Rica

Authors

  • Walter Cartín Sánchez Laboratorio de Estudios Especializados e Investigación
  • Kathia Valverde Muñoz Caja Costarricense del Seguro Social, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera"
  • Carlos Suárez Vargas Laboratorio de Estudios Especializados e Investigación
  • Jorge López Villegas Laboratorio de Estudios Especializados e Investigación

DOI:

https://doi.org/10.51481/amc.v52i3.664

Keywords:

hemoglobin H, alpha-thalassemia, hemolytic anemia

Abstract

Hemoglobin H (Hb H) disease is the most common form of thalassemia intermedia and has many features that require careful consideration in its management. In the majority of cases, the disease results from double heterozygosity for α0thalassemia due to deletions that remove both linked αglobin genes on one chromosome 16, and deletional α+ from single α-globin gene deletions on the other chromosome 16 resulting in a (--/-α) condition. The excess β globin chain precipitates and forms a characteristic abnormal hemoglobin: hemoglobin H a β globin tetramer (β4). In a steady state, patients with Hb H disease have hemoglobin levels around 9 to 10 g/dL however, during a hemolytic crisis, which frequently occur in or after acute infections causing high fever, the hemoglobin may drop significantly and the patients can develop shock or renal shutdown. Even though splenectomy leads to significant elevation of hemoglobin levels, it is not recommended because the majority of patients do well with said steady-state hemoglobin levels. We present here the first case of hemoglobin H (-α3.7/ --SEA) southeast Asia variant described in Costa Rica.

Downloads

Download data is not yet available.

References

Sáenz GF, Rodríguez W. Síndromes talasémicos. Nuevos conceptos y estado actual del conocimiento en Costa Rica. Act Méd Costarric 2006; 48:4.

Fuchaeron S, Viprakasit V. Hb H disease: clinical course and disease modifiers. American Society of Hematology. Education Program Book. New Orleans, Luisiana. 2009; 26-34.

Chui DH, Waye JS. Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem. Blood 1998; 91:2213-2222.

Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood 2003; 101:791-800.

Lau YL, Chan LC, Chan YY. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong - implications for population screening. N Engl J Med 1997; 336:1298-1301.

Higgs DR. Molecular basis of alpha thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Weatheall DJ. Disorders of Hemoglobin. Sec. Ed. Cambridge University Press, 2009: 241-265.

Downloads

Published

2010-06-14

How to Cite

Hemoglobin H Disease; First Case of Hemoglobin H Variant Type (-α3.7/ --SEA) in Costa Rica. (2010). Acta Médica Costarricense , 52(3), 177-179. https://doi.org/10.51481/amc.v52i3.664